Category: News

How to Apply for a Brain Cancer Research Pilot Grant in 2027: A Complete Guide for Researchers

Brain cancer remains one of the most underfunded areas in oncology research relative to its devastating impact. Glioblastoma multiforme (GBM), the most aggressive form of brain cancer, carries a median survival of 14 to 16 months following diagnosis. Meaningful advances in treatment outcomes depend on a consistent pipeline of early-stage, innovative research — the kind of exploratory, high-risk work that precedes the landmark studies and clinical trials that change patient care.

The problem is that most large funders — federal agencies, major foundations, and industry sponsors — require preliminary data before they will support a research project. That creates a gap: researchers with compelling scientific questions but no existing proof-of-concept often have nowhere to start.

BeWonderNow, Inc. was built specifically to fill that gap.

What Is BeWonderNow, Inc.?

BeWonderNow, Inc. is a nonprofit organization that provides seed funding for early-stage brain cancer research through a competitive pilot grant program. Founded with the mission of bridging the space between scientific innovation and large-scale research support, BeWonderNow awards grants ranging from $25,000 to $150,000 to physician-scientists and researchers at accredited U.S. institutions.

BeWonderNow operates two grant cycles per year — Spring and Fall — and has funded researchers at institutions including Harvard Medical School, Johns Hopkins University School of Medicine, Emory University School of Medicine, and the Children’s Cancer Therapy Development Institute.

BeWonderNow, Inc. is a recipient of the Innovators in Cancer Research Award.

Learn more at bwnfoundation.com.

Spring 2027 Pilot Grant Program: Key Dates and Details

The BeWonderNow Spring 2027 Pilot Grant Program is now open. This is the first of two 2027 funding cycles.

Spring 2027 Deadlines:

Letter of Intent (LOI) Deadline: March 16, 2027
Full Proposal Deadline: April 20, 2027 (by invitation only)
Funding Decision Announcement: June 14, 2027

Award Details:

Award range: $25,000 to $150,000 (direct costs)
Project duration: 12 to 24 months
Indirect costs allowed: up to 10%
Number of awards: varies by cycle

All applications begin with a one-page Letter of Intent. There is no full proposal without an invitation, and LOI review typically takes five business days.

Who Is Eligible to Apply?

BeWonderNow pilot grants are open to physician-scientists and researchers who meet the following criteria:

Affiliation with an accredited academic, medical, or research institution within the United States
Proposed research that addresses an early-stage, innovative question in brain cancer
Principal investigator status at the applying institution (co-investigators at other institutions are permitted)
Commitment to the BeWonderNow mission of advancing brain cancer discovery through bold, exploratory pilot work

There is no minimum or maximum career-stage requirement. Early-career researchers and established physician-scientists are both eligible and encouraged to apply. Prior BeWonderNow applicants who were not selected in a previous cycle are also eligible and encouraged to reapply.

For specific eligibility questions, contact Sandi Wewerka at sandi@bwnfoundation.com.

How to Apply: Step-by-Step

Step 1: Submit a Letter of Intent by March 16, 2027

The LOI is a single page and should include:

Project title and summary of specific aims
Brief methodology overview
Key personnel and estimated budget
A statement of how the proposed research aligns with the BWN mission

The LOI is not a full proposal. It is designed to be accessible and straightforward — a way for the BeWonderNow Board of Directors to assess mission alignment and scientific merit before inviting a full application.

Step 2: Await Invitation (within 5 business days)

Applicants who submit an LOI are notified within five business days of submission whether they are invited to submit a full proposal. Not all LOI applicants will be invited, but the review process is fast — researchers will not wait weeks for a response.

Step 3: Submit a Full Proposal by April 20, 2027

Invited applicants submit a complete proposal package including:

Five-page research proposal (with optional figures appendix)
Detailed budget and budget justification
NIH-format biosketch for all key personnel
Cover letter addressing the project’s significance and innovation
AI use statement

Step 4: Funding Decisions Announced June 14, 2027

The BeWonderNow Board of Directors reviews all full proposals. Funding decisions are announced June 14, 2027. Grantees are expected to begin their projects within the award period outlined in their proposal.

What Makes a Strong BeWonderNow Application?

Based on the program’s history and mission, the strongest applications share several characteristics:

A clearly defined scientific question. The best proposals do not describe a project — they articulate a question that has to be answered, by this team, with this approach.
Early-stage, high-potential work. BeWonderNow funds research that is too early for standard federal funding but too important to delay. If you already have the data for an R01, this may not be the right stage for a pilot grant.
A compelling unmet need. Applications that clearly connect the proposed work to a gap in current brain cancer knowledge — clinical, translational, or basic science — perform well in review.
A realistic and well-justified budget. Awards range from $25,000 to $150,000. A budget that matches the scope of the proposed pilot work is viewed favorably.
Start developing now. The strongest LOIs are written by researchers who gave themselves time to sharpen their scientific argument. With a March 16 deadline, researchers who begin in January have a meaningful advantage.

Frequently Asked Questions

Can I apply if I don’t have preliminary data?

Yes. BeWonderNow pilot grants are specifically designed for research at the stage before preliminary data exists. That is precisely the gap this program was built to fund.

What types of brain cancer research does BeWonderNow fund?

BeWonderNow funds innovative, early-phase research addressing unmet needs in brain cancer, broadly defined. This includes basic, translational, and clinical research approaches. Prior grantees have worked across a range of brain cancer types and scientific methodologies.

Is there a Fall 2027 cycle if I miss the Spring deadline?

Yes. BeWonderNow operates two cycles per year. The Fall 2027 cycle is expected to open in August 2027. Researchers who miss the Spring deadline are encouraged to use the additional time to further develop their proposals for Fall.

How long does it take to hear back after submitting an LOI?

Applicants are notified within five business days of LOI submission.

Can researchers from outside the United States apply?

No. The program is currently open to researchers at accredited institutions within the United States.

How do I submit?

Visit bwnfoundation.com/grant-information for the submission portal and full application guidelines.

Apply for the Spring 2027 BeWonderNow Pilot Grant

Brain cancer research moves forward one bold idea at a time. If you are a physician-scientist or researcher with an innovative early-stage question — and the drive to pursue it — BeWonderNow, Inc. wants to hear from you.

Letter of Intent Deadline: March 16, 2027

Submit your LOI and learn more at bwnfoundation.com/grant-information.

Questions? Contact Sandi Wewerka at sandi@bwnfoundation.com or 651-357-3679.

Spring 2027

BeWonderNow, Inc. Opens Fall 2026 Pilot Grant Applications — Last Brain Cancer Research Funding Cycle of the Year

BeWonderNow Inc. Fall 2026 Pilot Grant Cycle Open

BeWonderNow, Inc. is proud to announce that applications are now open for its Fall 2026 Pilot Grant Program — the second and final brain cancer research funding cycle of the year. Building on a strong Spring 2026 cycle that awarded grants to researchers at Harvard Medical School, Johns Hopkins University School of Medicine, Emory University School of Medicine, and the Children’s Cancer Therapy Development Institute, BeWonderNow is ready to fund the next wave of bold, early-phase brain cancer science.

For researchers who missed the Spring window — or whose work is ready for a new submission — this is the last opportunity to apply for a BeWonderNow pilot grant in 2026.

Spring 2026 Grantees:
· Yoav Binenbaum, MD, PhD — Boston Children’s Cancer and Blood Disorders Center / Wyss Institute of Biologically Inspired Engineering, Harvard Medical School
· Laurie Delatour, MD, PhD — Johns Hopkins University School of Medicine
· Tomas Garon-Mvudi, MD — Emory University School of Medicine
· Anthony Haight, Ph.D. — Children’s Cancer Therapy Development Institute

Fall 2026 Submission Deadlines:
· Letter of Intent: September 7, 2026
· Full Proposal: October 5, 2026
· Funding Decision Announcement: November 9, 2026

Awards range from $25,000 to $150,000 in direct costs, supporting projects of 12 to 24 months in duration. Indirect costs are allowed up to 10%. The program is open to physician-scientists and researchers affiliated with accredited academic, medical, or research institutions in the United States.

Applications begin with a one-page Letter of Intent. The LOI is designed to be brief and accessible — a straightforward entry point that allows the BeWonderNow Board of Directors to assess mission alignment before inviting a full proposal. Applicants are notified of their invitation status within five business days of LOI submission.

“Every cycle, we are inspired by the quality and ambition of the research ideas that come through this program,” said Sandi Wewerka of BeWonderNow, Inc. “Our Spring 2026 grantees are already advancing work that could reshape how we understand and treat brain cancer. We are eager to fund the next chapter.”

Full proposals, submitted by invitation only following LOI review, must include a five-page proposal with optional appendix, budget and budget justification, NIH biosketches for all key personnel, a cover letter, and an AI use statement. Funding decisions for the Fall cycle will be announced November 9, 2026.

Interested researchers are encouraged to submit their Letter of Intent early. For complete eligibility requirements, application guidelines, and submission instructions, visit bwnfoundation.com/grant-information.

Questions about eligibility or program alignment should be directed to Sandi Wewerka at sandi@bwnfoundation.com or 651-357-3679.

———

BeWonderNow, Inc. is a nonprofit organization providing seed funding for early-stage brain cancer research through pilot grants that bridge the gap between scientific innovation and large-scale support. BeWonderNow is a recipient of the Innovators in Cancer Research Award. Learn more at bwnfoundation.com.

Brain Tumor Awareness Month 2026: Why Early-Stage Research Changes Everything

Brain cancer surviver sitting being thankful for Brain Tumor Awareness month at BeWonderNow Inc.

700K+

Americans currently living with a brain tumor

94,000+

New primary brain tumor diagnoses expected in the U.S. in 2026

35.6%

5-year relative survival rate for malignant brain tumors

Brain cancer is the leading cause of cancer death in children & adolescents

May Is #GrayMay — and the Numbers Demand Our Attention

Every May, the brain tumor community asks the world to go gray. To wear the ribbon. To pause and acknowledge a disease that quietly devastates hundreds of thousands of lives each year — yet receives far less public attention than many other cancers.

Brain Tumor Awareness Month isn’t just a campaign. It’s an urgent call. Over 700,000 Americans are living with a brain tumor right now. More than 94,000 new primary brain tumor diagnoses are expected in the U.S. in 2026 alone. And despite decades of research, survival rates for the most aggressive forms — like glioblastoma multiforme (GBM) — have remained devastatingly low.

At BeWonderNow, Inc., we believe the next breakthrough isn’t hiding in a massive clinical trial. It’s sitting in a researcher’s mind — waiting for someone to believe in it first.

“In contrast to advances made in other types of cancer, brain cancer survival rates remain little-changed despite years of research.” — Wyss Institute at Harvard University

Why Brain Cancer Is So Hard to Treat

Brain cancer presents unique and compounding challenges that make it one of the most difficult diseases in oncology. Understanding these barriers is the first step toward dismantling them.

🧠

The Blood-Brain Barrier

The brain’s natural defense blocks more than 98% of conventional drugs from entering — making effective drug delivery extraordinarily complex.

🔬

Tumor Heterogeneity

Brain tumors like GBM contain multiple genetically distinct cell populations, allowing them to rapidly adapt and resist treatment.

📍

Location & Precision

Surgery in the brain carries immense risk. Incomplete removal is common, and what’s left behind often regrows more aggressively.

💊

Lack of Approved Treatments

Of the 100+ types of brain tumors, only a handful have approved therapies — and none for the most deadly forms are considered curative.

These aren’t reasons to give up. They’re reasons to fund the kind of bold, unconventional thinking that traditional grant mechanisms often overlook. The ideas that seem too new. Too risky. Too early.

The Funding Gap No One Talks About

Here’s a truth that doesn’t get enough airtime: the most transformative scientific breakthroughs don’t begin with a $3 million NIH grant. They begin with a hypothesis. A hunch. A researcher willing to pursue an idea that doesn’t yet have the preliminary data to compete for large-scale funding.

This is called the “Valley of Death” in medical research — the gap between a promising idea and the support needed to validate it. Many potentially game-changing discoveries never make it out of this valley simply because there’s no funding mechanism designed to take that early bet.

Idea / HypothesisPilot DataPeer ReviewMajor GrantClinical Trial

⬆ Most early-stage brain cancer ideas stall here, starved of the pilot data needed to compete for larger funding.

That’s exactly the gap BeWonderNow exists to fill.

How BeWonderNow Is Changing the Equation

BeWonderNow, Inc. provides seed funding — between $25,000 and $150,000 — for innovative, early-phase brain cancer research at accredited U.S. institutions. These are pilot grants: purpose-built to fund the spark before the flame.

By empowering physician-scientists and researchers at the very beginning of discovery, BeWonderNow bridges the critical gap between an innovative idea and the large-scale institutional support that typically follows validated results. The mission is clear: transform brain cancer from a diagnosis of limited options into one of innovation, progress, and hope.

🔭 Why Pilot Grants Are the Highest-Leverage Investment in Brain Cancer Research

Think of pilot grant funding as venture capital for science. A small, strategic investment at the right moment — before anyone else will take the risk — can unlock data that opens the door to millions in follow-on funding and years of productive research.

Pilot data is the key that unlocks NIH, DOD, and private foundation grants
Early-stage funding allows researchers to challenge conventional approaches without institutional pressure
A single successful pilot study can redirect an entire field of inquiry
BWN-funded research supports bold ideas that challenge the status quo — exactly the ones most likely to break through

BeWonderNow received the Innovators in Cancer Research Award in recognition of its groundbreaking approach to funding brain cancer research grants.

What “Innovative Thinking” Actually Looks Like

BeWonderNow’s grant philosophy centers on a belief that conventional boundaries in brain cancer research must be challenged. But what does that look like in practice?

It might be a researcher developing a sticky hydrogel that surgeons can spray directly into the brain post-surgery to deliver chemotherapy locally — bypassing the blood-brain barrier entirely. It might be a team investigating how tumor cells hijack healthy neural stem cells through extracellular vesicles. It might be a novel immunotherapy approach, an AI-assisted diagnostic model, or an entirely new class of molecule.

What these ideas share isn’t a known outcome. It’s a rigorous, curious, creative mind willing to ask a question nobody has asked before — and the conviction to pursue it. BeWonderNow funds that person, at that moment.

Wear Gray Day — May 27: A Simple Act with Meaning

📅 National Wear Gray Day · May 27, 2026

Go Gray This May 🩶

Gray is the color of gray matter — the nerve cell tissue at the heart of the brain. Wearing gray during Brain Tumor Awareness Month is a simple, visible act of solidarity with the 700,000+ Americans living with brain tumors, and a signal to the world that this community deserves more attention, more funding, and more hope.

On May 27th — National Wear Gray Day — we invite you to wear gray, post it with #GrayMay and #BeWonderNow, and help amplify the message that early-stage research funding can change what brain cancer means for the next generation.

5 Things You Can Do This Brain Tumor Awareness Month

Wear gray on May 27th and post with #GrayMay #BeWonderNow — every post reaches someone who may not know what’s at stake.
Share this article. Knowledge is the first form of advocacy. Help others understand why early-stage research funding is so critical.
Follow BeWonderNow on LinkedIn and social media to stay updated on our grant programs, funded research updates, and the researchers pushing the field forward.
Talk to researchers you know. If you’re in academic medicine, neuroscience, or oncology — our Spring 2026 Pilot Grant Program is actively seeking Letters of Intent. Awards range from $25,000 to $150,000.
Support the mission. Every dollar BeWonderNow receives goes toward funding the science that could change everything. Want to contribute to this work? Contact us to learn how to support BeWonderNow’s grant funding.

The Urgency Is Now

Brain Tumor Awareness Month exists because this disease doesn’t take a month off. Researchers are working late in labs right now on ideas that could, with the right support at the right moment, rewrite the prognosis for thousands of patients.

We don’t know yet which idea will be the one that changes everything. But we know this: it will need someone to believe in it first.

That’s what BeWonderNow does. And in #GrayMay, we ask you to believe in it too.

Ready to Support Early-Stage Brain Cancer Research?

Whether you’re a researcher, a donor, a patient advocate, or simply someone who cares — there’s a place for you in the BeWonderNow mission.

#GrayMay #BrainTumorAwarenessMonth #BeWonderNow #WearGrayDay #BrainCancerResearch #PilotGrants #EarlyStageResearch #BrainCancer #GBM #CancerInnovation

BeWonderNow, Inc. Opens Spring 2026 Pilot Grant Applications for Brain Cancer Research

BeWonderNow Inc. Spring Pilot Grant Cycle Open

BeWonderNow, Inc. is now accepting applications for its Spring 2026 Pilot Grant Program, providing seed funding for innovative, early-phase brain cancer research at accredited U.S. institutions.

The program awards between $25,000 and $150,000 in direct costs per project, supporting physician-scientists and researchers generating the critical preliminary data that opens the door to larger federal and industry funding. Project durations typically run 12 to 24 months, with indirect costs allowed up to 10%.

“We exist to fund the ideas that are too early for the NIH but too important to wait,” said Sandi Wewerka of BeWonderNow, Inc. “Brain cancer patients and families cannot afford a gap between bold scientific thinking and the resources to pursue it.”

Spring 2026 Submission Deadlines

Letter of Intent: May 8, 2026
Full Proposal: June 8, 2026
Funding Decision Announcement: July 13, 2026

All applicants must submit a one-page Letter of Intent prior to a full proposal. The LOI process allows the BeWonderNow Board of Directors — a multidisciplinary group of physician-scientists and researchers — to evaluate alignment with the foundation’s mission before requesting a complete application. Applicants are notified of their invitation status within five business days of LOI submission.

Eligible applicants must be affiliated with an accredited academic, medical, or research institution within the United States. Proposed research must focus on innovative, early-phase brain cancer research with strong scientific rationale and meaningful potential to advance discovery.

Full proposal requirements include a five-page proposal, budget and budget justification, NIH biosketches for all key personnel, a cover letter, and an AI use statement.

For complete grant guidelines, eligibility requirements, and submission instructions, visit bwnfoundation.com/grant-information.

Questions about eligibility or mission alignment should be directed to Sandi Wewerka at sandi@1246750.us16.myftpupload.com or 651-357-3679.

BeWonderNow, Inc. is a nonprofit organization providing seed funding for early-stage brain cancer research through pilot grants that bridge the gap between innovation and large-scale support. Learn more at bwnfoundation.com.

Be Wonder Now: Fueling Breakthroughs in Brain Cancer Research

woman in white coat holding black dslr camera

Brain cancer remains one of the most challenging diseases to treat, with limited treatment options and a long road ahead toward a cure. But thanks to the tireless work of nonprofit organizations like Be Wonder Now, there is new hope for researchers, patients, and families alike.

Founded on the belief that curiosity and compassion can drive meaningful change, Be Wonder Now has quickly become a vital supporter of innovative brain cancer research. Through their grant program, they are empowering scientists and medical teams to pursue bold ideas that traditional funding sources often overlook.

Supporting Bold, Innovative Research

While government and large institutional funding often go to projects with proven results, Be Wonder Now takes a different approach. Their mission is to back high-risk, high-reward research—the kind that could redefine how brain tumors are diagnosed, treated, and ultimately cured. By offering targeted grants to promising projects, the foundation is helping accelerate discoveries that could have a profound impact.

One of their most recent grant cycles funded research into precision therapies that use genetic mapping to identify the unique mutations driving tumor growth. Another grant supported the exploration of advanced imaging techniques that may allow doctors to detect brain tumors earlier and more accurately. These efforts are not just theoretical—they’re paving the way for real advancements in patient care.

A Community of Hope

Be Wonder Now is more than just a funding source—it’s a community. Families affected by brain cancer, survivors, and supporters are all part of the mission. Through storytelling and outreach, the foundation highlights the resilience of those fighting brain cancer while reminding us of the urgent need for continued research.

Their name, Be Wonder Now, reflects their philosophy: to embrace curiosity, ask the hard questions, and act with compassion in the present moment. This spirit of wonder fuels their commitment to backing researchers who dare to imagine a future free from brain cancer.

Looking Ahead

As Be Wonder Now continues to expand its grantmaking, the foundation is actively seeking to partner with more institutions, researchers, and advocates. Each grant represents not just funding, but a powerful belief in the potential of science to change lives.

For families touched by brain cancer, organizations like Be Wonder Now represent something priceless: hope. Hope that the next big discovery is just around the corner. Hope that researchers will have the resources they need to keep moving forward. And hope that one day, a diagnosis of brain cancer will no longer be a life sentence.

✨ To learn more about Be Wonder Now’s mission and the groundbreaking projects they support, visit their website and discover how you can get involved in fueling the future of brain cancer research.